LGR5 and malignant colon neoplasm: Preliminary investigations (data not shown) revealed that candidate markers differentially expressed between PC- and Lgr5+-initiated mouse tumors such as DCLK1 and HOXB9 were not equally discriminative among patient-derived colon cancers.